Caraway Therapeutics
Latest round
- Series A
Last raised
- Nov 2018
Total raised
- $23M
Investors
- 6
About Caraway Therapeutics
Rheostat Therapeutics Inc.Founded in 2018 and headquartered in Cambridge, US, Rheostat Therapeutics, Inc. develops therapeutic solutions for neurodegenerative disorders.Rheostat Therapeutics specializes in creating therapies for neurodegenerative diseases., Inc. to enhance its development of treatments for neurodegenerative diseases. With the financial backing from the acquisition, the company is expected to expand its research capabilities and market reach, specifically targeting regions with high healthcare needs.
Who invested in Caraway Therapeutics
6 investors across 1 round
See all investors in Caraway Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 26, 2018
Amount
$23M
Investors
Questions about Caraway Therapeutics
Who invested in Caraway Therapeutics?
Caraway Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Caraway Therapeutics raised?
Caraway Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Caraway Therapeutics last raise money?
Caraway Therapeutics's most recent round on record is a Series A, in Nov 2018.
What does Caraway Therapeutics do?
Caraway Therapeutics is a biotechnology company.
Where is Caraway Therapeutics headquartered?
Caraway Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Caraway Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Caraway Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Caraway Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.